Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
+6.42%
Месячное изменение
-13.43%
6-месячное изменение
+346.15%
Годовое изменение
+256.92%
Предыдущее закрытие
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
Объем
15
Рынки
Рынок акций США
Здравоохранение
IPSC
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
58.82 M
59.17 M
64.82 M
86.05 M
—
Valuation ratios
Enterprise value
876.43 M
209.81 M
188.61 M
28.46 M
-3.04 M
Price to earnings ratio
-5.36
-2.19
-1.6
-0.63
-6.12
Price to sales ratio
—
55.21
94.06
12.06
13.21
Price to cash flow ratio
-5.77
20.43
-2.38
-0.72
-1.82
Price to book ratio
1.3
0.95
1.14
0.49
0.65
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.22
0.27
0.38
0.36
0.6
Return on equity %
0.24
0.43
0.74
0.78
0.89
Return on invested capital %
179.14
271.7
318.66
240.44
419.32
Gross margin %
—
100
100
100
—
Operating margin %
—
2 574.17
6 556.87
2 096.48
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
2 518.41
6 115.12
1 920.87
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
14.57
10.72
9.92
1.5
30.16
Inventory turnover
—
—
—
—
—
Asset turnover
—
0.01
0.01
0.02
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0.02
0.01
0.01
—
—
Long term debt to total equity ratio
0.02
0.01
0.02
—
—
Per share metrics
Operating cash flow per share
2.75
0.24
1.53
1.4
1.33
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
6.88
5.46
2.99
2.41
7.67
Net current asset value per share
7.04
5.54
3.06
2.47
7.89
Tangible book value per share
12.23
5.24
3.2
1.62
7.69
Working capital per share
6.56
5.02
2.76
0.82
5.64
Book value per share
12.23
5.24
3.2
2.05
9.32
Новости
TD Cowen присваивает акциям Century Therapeutics рейтинг Buy
TD Cowen initiates Century Therapeutics stock rating at Buy
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Clear Street снизил целевую цену акций Century Therapeutics до $6,60
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics привлекает $135 млн через частное размещение
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors